Cancer-Cooling Protein Can Stop Disease Spreading
New Treatment Pathway:
Scientists reveal a potential treatment pathway for bowel cancer involving the immune system protein Ku70.
Ku70 can be activated to combat bowel cancer when triggered by a drug cocktail, as per a study in Science Advances.
Prevalence of Bowel Cancer:
Colorectal cancer is the third most common cancer in the U.S., with around 150,000 new cases annually.
Bowel cancer ranks as the second leading cause of cancer-related deaths in the U.S., with an estimated 53,000 deaths in 2024.
Importance of Early Detection:
Survival rates for bowel cancer increase significantly when detected early.
Ku70 as Immune Biomarker:
Ku70, an immune protein, is identified as a biomarker that predicts outcomes for individuals diagnosed with bowel cancer.
Potential Screening Method:
Future bowel cancer screening could involve checking Ku70 levels in abnormal growths to guide screening frequency.